New drug combo shows promise in controlling advanced colon cancer
NCT ID NCT03446157
First seen Mar 17, 2026 · Last updated Jun 14, 2026 · Updated 14 times
Summary
This study tested a combination of two drugs, palbociclib and cetuximab, in 24 adults with metastatic colon cancer that had certain gene types (KRAS/NRAS/BRAF wild-type). The goal was to see if the combo could shrink or stabilize tumors. The study is complete, but results are not yet reported here.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, 27599-7295, United States
Conditions
Explore the condition pages connected to this study.